"The three-year clinical trial results of the retinal implant popularly known as the 'bionic eye,' have proven the long-term efficacy, safety and reliability of the device that restores vision in those blinded by a rare, degenerative eye disease," according to
Medical News Today. "The findings show that the Argus II significantly improves visual function and quality of life for people blinded by retinitis pigmentosa. They are being published online today in
Ophthalmology, the journal of the American Academy of Ophthalmology."
Read more.
No comments:
Post a Comment